drugset / Trial / NCT05519514
Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
A randomized, open label, single dose, balanced, two treatment, two sequence, four period, fully replicate, cross over bioequivalence study under fasting condition.
Timeline
- Start
- 2021-07-12
- Primary completion
- 2021-08-08
- Completion
- 2021-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 9 mg | — |
Indications
No indication recorded.